NCT07182968 Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
| NCT ID | NCT07182968 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Systemic Sclerosis (SSc) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-04 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-08-04 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic sclerosis (SSc) physically and has been validated for reliability and validity, as it correlates with the modified Rodnan Skin Score (mRSS), which rheumatologists assess. Thus, it has been demonstrated to be an applicable and easy approach for assessing skin thickness in SSc patients through patient-reported measurements. This study aimed to develop a Turkish version of the PASTUL questionnaire and to provide for its use in the Turkish population.
Eligibility Criteria
Inclusion Criteria: * Individuals diagnosed with scleroderma, * Individuals aged 18 years and older Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Individuals who are unwilling to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07182968 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Systemic Sclerosis (SSc). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07182968 currently recruiting?
Yes, NCT07182968 is actively recruiting participants. Contact the research team at orkuntf@gmail.com for enrollment information.
Where is the NCT07182968 trial being conducted?
This trial is being conducted at Çankaya, Turkey (Türkiye).
Who is sponsoring the NCT07182968 clinical trial?
NCT07182968 is sponsored by Hacettepe University. The trial plans to enroll 50 participants.